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Antibacterial substances from actinomycetes were isolated from marine environment of Lonar Lake and 
characterized. Out of the 24 isolates subjected to secondary screening, 12 isolates were active against 
Bacillus subtilis, 13 against Staphylococcus aureus, 7 against Escherichia coli, 3 against Proteus 
vulgaris  and 4 against Salmonella typhi. Metabolites in the extract of broth of 48 hrgrown Streptomyces 
spp. culture no.2 proved to have antimicrobial and cytotoxic against human lung carcinoma cell A549. 
 





Actinomycetes are the most economical and biotechno-
logically valuable class of prokaryotes producing 
bioactive secondary metabolites notably antibiotics (Blunt 
and Prinsep, 2006) anti-tumor agents, immunosuppres-
sive agents (Mann, 2001) and enzymes (Berdy, 2005; 
Cragg and Newman, 2005; Strohl, 2004).  Actinomycetes 
are the main source of clinically important antibiotics, 
most of which are too complex to be synthesized by 
combinatorial chemistry, making three quarters of all 
known products; the Streptomyces are especially prolific, 
producing around 80% of total antibiotic products (Bull 
and Stach, 2005; Imada and Okami, 1998; Kim and 
Garson, 2005). Micromospora is the runner up with less 
than one-tenth as many as Streptomyces (Lam, 2006). In 
addition to antibacterial components they also produce 
secondary metabolites with biological activities of which 
the Streptomyces spp. amounts for 80% of the total 
production by actinomycetes (Cragg and Newman, 
2005).The aim of this study was to investigate the 
antimicrobial and cytotoxic activity of actinomycete 
isolates from Lonar Lake (Buldhana Dist, India). 
 
 
MATERIALS AND METHODS 
 
Isolation of actinomycetes and identification 
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Masayuki and Hideo, 1987) was used for the isolation of actinomy-
cetes.  The media components included cycloheximide (20 mg l-1), 
pravastatin (10 mg l-1), trimethoprim (2 mg l-1) and nalidixic acid (10 
mg l-1) to prevent other non-actinomycete bacteria and fungal 
growth (Baltz, 2006). The samples were diluted with sterilized water 
and an aliquot of 0.1 ml from these samples was spread on the 
media. After incubation of 1 – 3 days at 28oC, the actinomycete 
colonies that developed on the plates were enumerated and were 
expressed in colony forming units.  
In preliminary screening, determination of the antimicrobial 
activity of pure isolates was done by zone of inhibition method on 
Nutrient agar (NA) using Salmonella typhi NCIM 2501 as pathogen. 
Further screening was performed by zone of inhibition method 
against the standard test organisms. Actinomycetes were cultured 
for the screening of antibiotic substances in nutrient agar at 28oC 
for 3 days. The test organisms used were: Bacillus subtilis 
NCIM2722, Staphylococcus aureus NCIM 2127, Escherichia coli 
NCIM 2995, Proteus vulgaris NCIM2857, Pseudomonas aeruginosa 




Identification of actinomycetes 
 
The characterization of screened culture was conducted using 
biochemical assays including NaCl resistance, casein hydrolysis, 
starch hydrolysis, Tween 20 hydrolysis, urea hydrolysis, esculin 
hydrolysis, acid production from sugar, temperature tolerance and 
morphological characterization methods included macroscopic and 
microscopic determination. The structures observed under oil 
immersion (100X) were compared with Bergey’s manual of 
Determinative Bacteriology, Ninth edition (2000).  
 
 
Isolation and purification of antibacterial metabolites 
 
Samples from  Streptomyces  Culture  No.2  grown  in  1 L  nutrient  










broth at 28oC and 220 rpm were taken and extraction was carried 
out using ethyl acetate solvent extraction  [ethyl acetate : filtrate 1:1  
(v/v)] on shaker at 220 rpm  for 1 h. The ethyl acetate phase that 
contains antibiotic was separated from the aqueous phase and by 
evaporation in water bath at 80-90°C the residue was obtained and 
weighed. The compound thus obtained was used to determine 
antimicrobial activity and minimum inhibitory concentration.  
The antimicrobial activity was determined by spectrophotometric 
method. The residue obtained was dissolved in 1 ml 0.2 M phos-
phate buffer (pH 7.0). 100 l of preparation was loaded into a well 
in the 24 well plates, containing pathogenic cultures and were 
incubated at 37°C for 18 - 48 h and optical densities measured at 
540 nm using ELISA plate reader (Figure 3). 
For thin layer chromatography (Becker and Lechavier, 1964), 
silica gel plates (Merck) 5 X 20 cm, 1 mm thick were used. 10 l of 
the ethyl acetate fractions and reference antibiotics were spotted on 
the plates and the chromatogram was developed using ethylacetate 





Human Lung carcinoma cells-A549 cell lines were grown in 
Dulbecco's Modified Eagle Medium (DMEM) supplemented with 
10% fetal calf serum (FCS). For cytotoxicity assays, cells were 
seeded into 24-well plates at a density of 2.1 × 105 cells/well and 
the dilutions (1:500 and 1:1000) of the extract made in DMEM in the 
volumes of 10 µl and 25 µl were added. After incubation period (24, 
48 h), the growth media was removed and the cells were 
trypsinized and counted in a Hemocytometer (Freshney, 2006). 
 
 
RESULTS AND DISCUSSION 
 
Identification of actinomycetes 
 
Out of 32 actinomycetes subjected for primary screening 
process, only 24 isolates showed activity against test 
organisms. Of which, only 3 were active against gram  
negative organism, 12 against gram positive organisms 
and 12 against both gram  positive and gram negative 
organisms. Among these isolates, 31 of them showed 
positive inhibitory effect against B. subtilis, 27 against S. 
aureus, 17 against E. coli, 15 against S. typhi and 14 
against Proteus species. 
 Out of the 24 isolates those were subjected for the 
secondary screening, 12 isolates were active against B. 
subtilis, 13 against S. aureus, 7 against E. coli, 3 against 
P. vulgaris and 4 against S. typhi. From Figure 1, it can 
be seen that the actinomycete culture no 2 shows 
maximum zone of inhibition against pathogenic culture. 
Culture no 2 which is of Streptomyces showed activity 
against all pathogenic strains (Figure 2). Figure 3 
extrapolates the effect of extract of 48 h grown culture of 
Streptomyces spp. colony 2 on various pathogenic 
cultures in the form of optical densities obtained. 
Identification of the potent antibiotic producing strains 
reveals that most of the specimens belong to the genus 
Streptomyces followed by Streptoverticillium. The mini-
mum inhibitory concentration of the extract from 
Streptomyces spp. no.2 was 0.73 mg.mL-1. Also the 
results from thin layer chromatography showed the spot 
given by the extract of Streptomyces spp. was with Rf 





We examined the effect of Streptomyces spp. and its 
metabolites on the growth of eukaryotic cells. For the cyt-
otoxicity studies A549 cells were chosen. Monolayer 
cultures of A549 cells were exposed to various 
concentrations of the extracts and cell viability evaluated 
by counting live cells after 24 and 48 h of exposure 
(Figures 4 and 5). The extract caused cell death at 
dilutions of 1/500 (10 µl). At dilution of 1/1000 (25 µl) cell 





Actinomycetes are producers of potent metabolic com-
pounds used commercially as antibiotics and other novel 
drugs (Shiomi and Takeuchi, 1990). Our work justifies the 






Figure 2. 25 µl of 48 h grown culture (1st, 2nd 3rd and 4th) of Streptomyces spp. 
Streptomyces spp. no.2 shows antimicrobial activity against all pathogenic strains. 1. 
Bacillus subtilis NCIM2722, 2. Staphylococcus aureus NCIM 212, 3. Escherichia coli 
NCIM 2995 ,4. Proteus vulgaris NCIM2857, 5. Pseudomonas aeruginosa NCIM 2074, 






Figure 3. Effect of extract of 48 h grown culture of Streptomyces spp. no.2 of 
actinomycetes on various pathogenic cultures. 1. Bacillus subtilis NCIM2722, 2. 
Staphylococcus aureus NCIM 2127, 3. Escherichia coli NCIM 2995, 4. Proteus vulgaris 






Figure 4. Cytotoxic effect of extract of 48 h grown culture of Streptomyces spp. no. 2 on Lung 
carcinoma cells A549.  





     a                                            b      c  
 
Figure 5. Lung carcinoma cells A549. a) Cells with 0 l of extract of 48 h grown colony no . 2. b) 
Cells with 10 l of extract  of 48 h grown colony no . 2. c) Cells with 25 l of extract of 48 h grown 




broad host range exhibited by the metabolites of the 
actinomycetes isolated using the above described 
methods and sources, which came to include even 
eukaryotes along with previously established action 
against prokaryotes. We also found that the metabolite 
from Streptomyces spp. colony 2 had inhibitory action 
against the growth of human lung carcinoma A549 cell 
line. Hence anti-cancerous property shown by this 
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